4D Molecular Therapeutics, Inc. FDMT
- 4D-150 — Wet Age-Related Macular Degeneration Phase 3
- 4D-150 — Diabetic Macular Edema Phase 2
VEGF-B (1 companies · 2 programs)
Companies with an active program directed at VEGF-B.
Companies with an active program directed at VEGF-B.